Balaji Amines Limited (IN:BALAMINES)
:BALAMINES
Want to see IN:BALAMINES full AI Analyst Report?
Top Page
Balaji Amines Limited
(BALAMINES)
Select Model
Select Model
Rating:66Neutral
Price Target:
₹1,752.00
▲(60.62% Upside)
Action:Reiterated
Date:05/15/26
The score is driven by a strong balance sheet and bullish technical trend, offset by weakened cash-flow quality in FY2026 (negative free cash flow and weaker cash conversion) and only moderate valuation support (P/E ~18.9 with a low dividend yield).
Positive Factors
Low leverage and strong balance sheet
Very low leverage gives Balaji Amines durable financial flexibility: it can fund working capital swings, invest in capacity, or withstand sector cyclicality without high refinancing risk. Over the next 2–6 months this reduces solvency risk and preserves strategic optionality for growth or restructuring.
Negative Factors
Material negative free cash flow in FY2026
A materially negative free cash flow indicates heavier reinvestment or working-capital strain that can erode liquidity despite low debt. Over the next 2–6 months this may constrain the company’s ability to fund dividends, opportunistic capex, or buffer cyclical weakness without drawing on reserves or new financing.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage and strong balance sheet
Very low leverage gives Balaji Amines durable financial flexibility: it can fund working capital swings, invest in capacity, or withstand sector cyclicality without high refinancing risk. Over the next 2–6 months this reduces solvency risk and preserves strategic optionality for growth or restructuring.
Read all positive factors
Balaji Amines Limited (BALAMINES) vs. iShares MSCI India ETF (INDA)
Market Cap
₹57.17B
Dividend Yield0.97%
Average Volume (3M)3.13K
Price to Earnings (P/E)18.9
Beta (1Y)0.91
Revenue Growth2.00%
EPS Growth7.14%
CountryIN
Employees1,084
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)45.00
Shares Outstanding32,401,000
10 Day Avg. Volume2,179
30 Day Avg. Volume3,132
Financial Highlights & Ratios
PEG Ratio3.06
Price to Book (P/B)1.60
Price to Sales (P/S)2.22
P/FCF Ratio-18.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)36.9
Revenue Forecast (FY)₹15.75B
Balaji Amines Limited Business Overview & Revenue Model
Company Description
Balaji Amines Limited engages in the manufacture and sale of methylamines, ethylamines, and derivatives of specialty chemicals and pharma excipients in India. The company operates through three segments: Amines & Speciality Chemicals, Hotel, and C...
How the Company Makes Money
Balaji Amines makes money primarily by manufacturing and selling amines and amine-based chemical derivatives/intermediates to industrial customers. Its core revenue model is B2B product sales: it produces bulk and specialty amines (and related der...
Balaji Amines Limited Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
78
Positive
Cash Flow
45
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.64B | 14.25B | 13.97B | 16.08B | 23.38B | 23.20B |
| Gross Profit | 5.56B | 4.88B | 4.88B | 3.50B | 8.39B | 8.57B |
| EBITDA | 2.52B | 2.65B | 2.65B | 3.53B | 6.24B | 6.36B |
| Net Income | 1.46B | 1.67B | 1.58B | 2.05B | 3.26B | 3.68B |
Balance Sheet | ||||||
| Total Assets | 23.31B | 27.43B | 22.52B | 21.46B | 19.63B | 18.75B |
| Cash, Cash Equivalents and Short-Term Investments | 1.86B | 2.71B | 3.50B | 3.31B | 3.09B | 515.37M |
| Total Debt | 314.46M | 1.33B | 110.27M | 196.97M | 575.74M | 1.01B |
| Total Liabilities | 2.75B | 5.91B | 2.34B | 2.53B | 2.65B | 5.60B |
| Stockholders Equity | 18.82B | 19.76B | 18.45B | 17.22B | 15.54B | 12.50B |
Cash Flow | ||||||
| Free Cash Flow | -1.62B | -1.74B | 874.82M | 704.14M | 2.62B | 842.07M |
| Operating Cash Flow | 222.05M | 1.96B | 2.73B | 3.34B | 3.82B | 2.32B |
| Investing Cash Flow | -1.15B | -3.58B | -1.61B | -1.64B | -1.86B | -1.47B |
| Financing Cash Flow | -169.00M | 865.75M | -447.73M | -749.66M | -812.33M | -565.13M |
Balaji Amines Limited Technical Analysis
Positive
1090.80
Price Trends
1201.98
Positive
1166.82
Positive
1282.32
Positive
Market Momentum
135.80
Negative
72.56
Negative
89.28
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BALAMINES, the sentiment is Positive. The current price of 1090.8 is below the 20-day moving average (MA) of 1425.46, below the 50-day MA of 1201.98, and below the 200-day MA of 1282.32, indicating a bullish trend. The MACD of 135.80 indicates Negative momentum. The RSI at 72.56 is Negative, neither overbought nor oversold. The STOCH value of 89.28 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:BALAMINES.
Balaji Amines Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ₹87.47B | 34.71 | ― | 0.62% | -2.29% | -3.26% | |
66 Neutral | ₹57.17B | 18.92 | ― | 0.97% | 2.00% | 7.14% | |
64 Neutral | ₹155.08B | 76.50 | ― | 0.06% | 66.49% | 112.13% | |
64 Neutral | ₹27.72B | 11.40 | ― | 0.09% | 15.19% | 9.27% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
52 Neutral | ₹7.77B | 101.17 | ― | 1.07% | -14.55% | -74.70% | |
47 Neutral | ₹44.69B | 102.02 | ― | 0.09% | 10.86% | -17.60% |
* Basic Materials Sector Average
IN:BALAMINES
Balaji Amines Limited
1,713.65
281.66
19.67%
IN:ALKYLAMINE
Alkyl Amines Chemicals Limited
1,768.20
17.65
1.01%
IN:ANURAS
Anupam Rasayan India Ltd.
1,352.35
393.58
41.05%
IN:FAIRCHEMOR
Fairchem Organics Ltd
604.30
-213.00
-26.06%
IN:NEOGEN
Neogen Chemicals Ltd.
1,580.60
16.55
1.06%
IN:ROSSARI
Rossari Biotech Ltd
504.50
-151.70
-23.12%
Balaji Amines Limited Corporate Events
Balaji Amines launches shareholder campaign on KYC and demat window
May 9, 2026
Balaji Amines Limited announced that it has published newspaper advertisements in The Indian Express and Pudhari as part of the second 100 days ‘Saksham Niveshak’ campaign, aimed at promoting KYC updates and other shareholder-related i...
Balaji Amines Opens Special Window for Transfer and Demat of Physical Shares
Mar 5, 2026
Balaji Amines Limited has announced that it has published newspaper advertisements in The Indian Express and Lokmat regarding a special window for the transfer and dematerialisation of physical shares. The move reflects the company’s ongoing...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.